Simple Summary Life expectancy in Western countries and East Asian countries has
incremented over the past decades, resulting in a rapidly aging world, while in general …

Purpose The aim of this study was to report on the safety (complications) and efficacy
(oncological and functional outcomes) of robot-assisted radical prostatectomy (RARP) …

Prostate cancer is the second most frequent malignancy among male worldwide and fourth
common malignancy in Japanese men [1, 2]. According to the latest annual statistical survey …

With increasing global life expectancy comes increasing health conditions. Robotic-assisted
radical prostatectomy (RARP) is traditionally offered to patients under the age of 75 years …

Objective The present study aimed to evaluate oncologic outcomes, patient-reported
outcomes (PROs), and frailty in older adult patients aged≥ 75 years who underwent robot …

Older men undergoing robot-assisted radical prostatectomy (RARP) have been thought to
have worse perioperative, functional and oncological outcomes than younger men …

Purpose To compare overall survivals (OSs) and cancer-specific survivals (CSSs) after
robotic-assisted radical prostatectomy (RARP) and radiation therapy (RT), the latter of which …

Introduction and objective Although advanced age doesn't seem to impair oncological
outcomes after robot-assisted radical prostatectomy (RARP), elderly patients have increased …

Objectives To investigate perioperative, oncologic, and functional outcomes of robot-
assisted radical prostatectomy (RARP) in men of age≥ 75 years in comparison with …

Objectives The aim of this study was to assess whether age≥ 75 years impairs surgical,
functional, and oncological outcomes after robot-assisted radical prostatectomy (RARP) …